These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 5818759)

  • 1. The distribution of the butyrophenones haloperidol, trifluperidol, moperone, and clofluperol in rats, and its relationship with their neuroleptic activity.
    Janssen PA; Allewijn FT
    Arzneimittelforschung; 1969 Feb; 19(2):199-208. PubMed ID: 5818759
    [No Abstract]   [Full Text] [Related]  

  • 2. On the distribution and metabolism of neuroleptic drugs. II. Pharmacokinetics of moperone.
    Heykants JJ; Lewi PJ; Janssen PA
    Arzneimittelforschung; 1970 Sep; 20(9):1238-42. PubMed ID: 5536800
    [No Abstract]   [Full Text] [Related]  

  • 3. Distribution and metabolism of neuroleptic drugs. I. Pharmacokinetics of haloperidol.
    Lewi PJ; Heykants JJ; Allewijn FT; Dony JG; Janssen PA
    Arzneimittelforschung; 1970 Jul; 20(7):943-8. PubMed ID: 5536066
    [No Abstract]   [Full Text] [Related]  

  • 4. Distribution, excretion and metabolism of neuroleptics of the butyrophenone type. I. Excretion and metabolism of haloperidol and nine related butyrophenone-derivatives in the Wistar rat.
    Soudijn W; Van Wijngaarden I; Allewijn F
    Eur J Pharmacol; 1967 Jan; 1(1):47-57. PubMed ID: 6058899
    [No Abstract]   [Full Text] [Related]  

  • 5. Analytical and pharmacokinetic studies on butyrophenones.
    Marcucci F; Mussini E; Airoldi L; Fanelli R; Frigerio A; de Nadai F; Bizzi A; Rizzo M; Morselli PL; Garattini S
    Clin Chim Acta; 1971 Sep; 34(2):321-32. PubMed ID: 5113569
    [No Abstract]   [Full Text] [Related]  

  • 6. On the distribution and metabolism of neuroleptic drugs. 3. Pharmacokinetics of trifluperidol.
    Lewi PJ; Heykants JJ; Janssen PA
    Arzneimittelforschung; 1970 Nov; 20(11):1701-5. PubMed ID: 5536974
    [No Abstract]   [Full Text] [Related]  

  • 7. Pharmacology of three mammotropic butyrophenones in the rat.
    Givant Y; Shani J; Goldhaber G; Serebrenik R; Sulman FG
    Arch Int Pharmacodyn Ther; 1973 Oct; 205(2):317-27. PubMed ID: 4797373
    [No Abstract]   [Full Text] [Related]  

  • 8. [Phenamine antagonism as a treat for experimental evaluation of neuroleptics].
    Raevskiĭ KS
    Farmakol Toksikol; 1973; 36(2):149-54. PubMed ID: 4151668
    [No Abstract]   [Full Text] [Related]  

  • 9. On the distribution and metabolism of azaperone (R 1929) in the rat and pig.
    Heykants J; Pardoel L; Janssen PA
    Arzneimittelforschung; 1971 Jul; 21(7):982-4. PubMed ID: 4935894
    [No Abstract]   [Full Text] [Related]  

  • 10. A method for the gas chromatographic determination of butyrophenones.
    Marcucci F; Airoldi L; Mussini E; Garrattini S
    J Chromatogr; 1971 Jul; 59(1):174-7. PubMed ID: 5110280
    [No Abstract]   [Full Text] [Related]  

  • 11. Distribution of haloperidol and trifluperidol in brain and blood of rats.
    Marcucci F; Airoldi L; Mussini E; Garattini S
    Chem Biol Interact; 1972 May; 4(6):427-30. PubMed ID: 5030587
    [No Abstract]   [Full Text] [Related]  

  • 12. [Polarographic determination of p-fluor substituted butyrophenone derivatives].
    Volke J; Wasilewska L; Ryvolová-Kejharová A
    Pharmazie; 1971 Jul; 26(7):399-400. PubMed ID: 5094366
    [No Abstract]   [Full Text] [Related]  

  • 13. The influence of various neuroleptic drugs on shock avoidance responding in rats. 3. Amphetamine antagonism in the discriminated Sidman avoidance procedure.
    Niemegeers CJ; Verbruggen FJ; Janssen PA
    Psychopharmacologia; 1970; 17(2):151-9. PubMed ID: 5443882
    [No Abstract]   [Full Text] [Related]  

  • 14. Bromoperidol, a new potent neuroleptic of the butyrophenone series. Comparative pharmacology of bromoperidol and haloperidol.
    Niemegeers CJ; Janssen PA
    Arzneimittelforschung; 1974 Jan; 24(1):45-52. PubMed ID: 4406109
    [No Abstract]   [Full Text] [Related]  

  • 15. Correlation between catalepsy and dopamine decrease in the rat striatum induced by neuroleptics.
    Honma T; Fukushima H
    Neuropharmacology; 1976 Oct; 15(10):601-7. PubMed ID: 1033478
    [No Abstract]   [Full Text] [Related]  

  • 16. Is it possible to predict the clinical effects of neuroleptic drugs (major tranquillizers) from animal data? IV. An improved experimental design for measuring the inhibitory effects of neuroleptic drugs on amphetamine-or apomorphine-induced "Cheroing" and "agitation" in rats.
    Janssen PA; Niemegeers CJ; Schellekens KH; Lenaerts FM
    Arzneimittelforschung; 1967 Jul; 17(7):841-54. PubMed ID: 5632842
    [No Abstract]   [Full Text] [Related]  

  • 17. The nerve impulse-blocking actions of tranquilizers and the binding of neuroleptics to synaptosome membranes.
    Seeman P; Staiman A; Chau-Wong M
    J Pharmacol Exp Ther; 1974 Jul; 190(1):123-30. PubMed ID: 4847308
    [No Abstract]   [Full Text] [Related]  

  • 18. [Restraint ulcers in rats. II. Study of protective substances].
    Buchel L; Gallaire D
    Arch Sci Physiol (Paris); 1967; 21(4):537-52. PubMed ID: 6077798
    [No Abstract]   [Full Text] [Related]  

  • 19. Computer procedures for evaluating the results of studies on the distribution and metabolism of drugs in the body.
    Lewi PJ; Chandler AE; van Riel DG; Somers PJ; Allewijn FT; Dony JG; Janssen PA
    Arzneimittelforschung; 1970 May; 20(5):684-93. PubMed ID: 5468058
    [No Abstract]   [Full Text] [Related]  

  • 20. The influence of various neuroleptic drugs on shock avoidance responding in rats. II. Nondiscriminated Sidman avoidance procedure with alternate reinforcement and extinction periods and analysis of the interresponse times (IRT's).
    Niemegeers CJ; Verbruggen FJ; Janssen PA
    Psychopharmacologia; 1969; 16(3):175-82. PubMed ID: 5391696
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.